MEET OUR TEAM
Gary E. Sabins
Gary is a veteran musculoskeletal and cardiovascular medical device executive. Most recently he was President & CEO of Renascent Medical, Inc. (RMI) and Spinal Restoration, Inc. (SRI) both Austin, TX based, venture backed spinal biologic/medical device product start-ups. Prior to RMI, Gary was the President of Sulzer Orthopedics, Inc. a global company with annual sales of over half a billion dollars with 1800 employees. During his tenure at Sulzer Orthopedics, he grew annual revenue from $80M to over $650M during an eight year period. Gary has extensive management experience and has assumed increasing responsibilities since he began his career with American Hospital Supply Corp. (Edwards Laboratories Division) / Baxter Healthcare Corp. and has spent many years in the highest levels of executive leadership in healthcare related companies. Gary has recently served on the Board of RMI, SRI, and is currently on the Advisory Board of the Austin Technology Incubator and Summit MedVentures. He is also a Board Member of NeuroChaos, Inc., a Board Member and past Chairman of the Austin Technology Council and the Chairman of TVA Medical, Inc. Gary is known as a high impact leader with the unique abilities to work effectively across cultural, geographical and technological boundaries as well as within complex organization and start-ups. In particular, Gary is well regarded for his strategic, operational and collaboration skills, leadership skills, sound ethics and strong results. Gary holds a B.A. degree from San Diego State University and has participated and taught in a wide range of ongoing leadership and executive development courses throughout his career.
William E Cohn, MD
William (Billy) Cohn, MD, is a cardiovascular surgeon and the Director of Minimally Invasive Surgical Technology at the Texas Heart Institute at St. Luke’s Episcopal Hospital in Houston, Texas. He is the co- director of the Cullen Cardiovascular Research Laboratory and a Professor of Surgery at Baylor College of Medicine and Adjunct Professor of Bioengineering at The University of Houston. Billy received his undergraduate degree from Oberlin College, and received his MD from Baylor College of Medicine, where he remained for general surgical and cardiothoracic surgical residency training. There Billy served as the last chief resident under the legendary Michael DeBakey. After graduation, he took a teaching position at Harvard Medical School where he rose to the rank of Associate Professor of Surgery and served as an attending cardiothoracic surgeon and Director of Minimally Invasive Surgery at the Beth Israel Deaconess Medical Center for 12 years. Billy has more than 80 United States patents awarded or pending for his medical innovations and has been honored as the Distinguished Inventor of the Year by the Intellectual Property Owners Association. In addition to TVA Medical, Inc., Billy is founder or co-founder of numerous medical device companies, including Sentreheart, Houston Medical Robotics, Apaxis and others focusing on the development of new minimally invasive therapies. Billy is also a Venture Partner with Santé Ventures.
James Eadie, MD
James served in the Air Force and was the medical director and Vice-Chair of Emergency Medicine at Wilford Hall Medical Center, an academic level-one trauma center in San Antonio. He completed two tours in Iraq as a critical care transport team chief and as the emergency department commander. He separated honorably as a major in 2008. James received his MBA from the University of Texas McCombs School Of Business, his MD from Harvard Medical School, and a BS in bioengineering, Summa Cum Laude, from the University of Michigan. He is board certified in emergency medicine and completed his residency at Massachusetts General Hospital and Brigham and Women’s Hospital.
Brian R Smith
Brian serves as the managing director of S3 Ventures, an earlier stage venture capital firm with $170M under management. Brian oversees all of S3′s investments. S3 invests primarily in Texas and the southwest. Brian co-founded the Convergent Investors Fund prior to S3, a $70M early-stage venture capital firm in Texas where he oversaw investments in 10 companies. At age 29, he founded and served as chairman and CEO of Crossroads Systems (Nasdaq: CRDS). He led Crossroads through five rounds of venture, strategic and mezzanine financing and to a successful IPO in 1999. Brian ran Crossroads as a public company for nearly four years. He was awarded the prestigious Ernst & Young Entrepreneur of the Year Award in 2000. Brian earned a BSEE with honors from the University of Cincinnati and an MSEE from Purdue University. He served on the board of Conformative Systems (acquired by Intel), Chicory Systems (acquired by CEVA), Crossroads Systems (Nasdaq: CRDS), LibreDigital (acquired by RRD), Phurnace (acquired by BMC Software), Sipera System (acquired by Avaya, Inc,) and StoredIQ (acquired by IBM). He currently serves on the boards of Alkami, BlueCava, Digby, Gravitant, Invodo, Kimbia, OrthoAccel, Packet Design, Tango Health and TVA Medical.
Adam L Berman
Adam is an experienced medical device leader with a focus on minimally-invasive cardiovascular technology Commercialization, R&D and Operations. Adam co-Founded TVA with Billy Cohn, built the team and has lead the strategy and execution of the company since its inception, including venture and strategic investment rounds.
In prior roles, Adam has been responsible for the development and commercialization of cardiovascular laser ablation systems, cardiovascular anastomotic devices and robotic surgical systems. His past companies include Coalescent Surgical, Inc. (now Medtronic), MedicalCV, Inc., Castlewood Surgical and Computer Motion, Inc. (now Intuitive Surgical).
Adam received his BSE Magna Cum Laude in Biomedical Engineering from Rensselaer Polytechnic Institute and his MSE in Bioengineering from the University of Washington.